Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study

PURPOSE: It has been reported that the overexpression of reactive oxygen species modulator 1 (Romo1) is significantly associated with poor survival outcomes in patients with lung cancer who received surgical resection, conventional fractionated radiotherapy, and chemotherapy. In this study, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Moonkyoo, Sung, Ji-Youn, Lee, Seung Hyeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455601/
https://www.ncbi.nlm.nih.gov/pubmed/32904444
http://dx.doi.org/10.2147/OTT.S266344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455601/
https://www.ncbi.nlm.nih.gov/pubmed/32904444
http://dx.doi.org/10.2147/OTT.S266344

Ejemplares similares